References
- Andersen P. H., Grønvald F. C., Hohlweg R., Hansen L. B., Guddal E., Braestrup C., Nielsen E. B. NNC 112, NNC 687 and NNC 756, new selective and highly potent dopamine D1 receptor antagonists. European Journal of Pharmacology 1992; 219: 45–52
- Burchell B., Coughtrie M. W. H. UDP-glucuronosyltranferases. Pharmacology and Therapeutics 1989; 43: 261–289
- Dutton G. J. Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton 1980
- Green M. D., Oturo E. M., Tephly T. R. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metabolism and Disposition 1994; 22: 799–305
- Guengerich F. P. Analysis and characterization of enzymes. Principles and Methods of Toxicology 2nd edn, A. W. Hayes. Raven, New York 1989; 777–814
- Hansen K. T., Thomsen K. F., Bundgaard H. Glucuronidation of the dopamine D-1 receptor antagonists NNC 0756 and NNC 0772 in liver microsomes. Drug Metabolism and Disposition 1992; 20: 172–178
- Mackenzie P. I., Lang M. A., Owens I. S. Effect of different detergent systems of the molecular size of UDP glucuronosyltransferase and other microsomal drug-metabolizing enzymes. Membrane Biochemistry 1984; 5: 193–207
- Matsubara T., Masakiro K., Akira T., Yoshihiro T., Koichi S. Quantitative determination of cytochrome P450 in rat liver homogenate. Analytical Chemistry 1976; 75: 596–603
- Nielsen E. B., Andersen P. H. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-112, new selective dopmaine D1 receptor antagonists. European Journal of Pharmacology 1992; 219: 35–44
- Peterson G. L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analytical Chemistry 1977; 83: 346–356
- Scragg I. M., Arion W. J., Burchell B. Microsomal membrane integrity and expression of UDP-glucuronosyltranferase in response to UDP-N-acetyl glucosamine. Advances in Glucuronide Conjugation, S. Mattern, K. W. Boch, W. Gerok. MTP Press, Lancaster 1985; 390–391
- Tedford C. E., Ruperto V. B., Barnett A. Characterization of a rat liver glucuronosyl-tranferase that glucuronidates the selective D1 antagonist SCH 23390, and other benzazepines. Drug Metabolism and Disposition 1991; 19: 1152–1159
- Tedford C. E., Ruperto V. B., Coffin V. L., Cohen M., Libonati M., Barnett A. SCH 39166, a novel dopamine D1 receptor antagonist: in vitro investigation of its glucuronidation and potential species differences. Drug Development Research 1992; 26: 389–403
- Tephly T. R. Isolation and purification of UDP-glucuronosyltransferases. Chemical Research and Toxicology 1990; 3: 509–516
- Tephly T. R., Coffman B., Styczynski P., Rios G., Charkowki D. M., Vanrollins M., McQuade R. D., Tedford C. E. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes. Drug Metabolism and Disposition 1994; 22: 713–718
- Tukey R. H., Pendurthi U. R., Nguyen N. T., Green M. D., Tephly T. R. Cloning and characterization of rabbit liver UDP-glucuronosyltranferase cDNAs. Journal of Biological Chemistry 1993; 268: 15260–16266
- Zakim D., Dannenberg A. J. How does microsomal membrane regulate UDP-glucuronosyltranferases. Biochemistry Pharmacology 1992; 43: 1385–1393